Physician
Howeedy, Aly
Howeedy, Aly was paid $147K by Medicaid between Jan 2018 and Jun 2021, across 79 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 19% of everything it billed.
33Billing provider infoHOWEEDY, ALY
PLANTATION, FL 33324
PLANTATION, FL 33324
33aNPI1770557035assigned 02/14/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$147K
24GClaims83,051
24DCodes billed79
24AFirst – last monthJan 2018 – Jun 2021
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Rank by total paid#64 of 207
Median peer was paid$39K
This provider vs. median3.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,912 | $10K | |
| 2019 | 23,191 | $31K | |
| 2020 | 26,016 | $57K | |
| 2021 | 18,932 | $50K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19% | 612 | 454 | $29K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 529 | 441 | $15K |
| 80053 | Comprehensive metabolic panel | 9.5% | 7,745 | 4,601 | $14K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.8% | 207 | 192 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.7% | 8,093 | 4,317 | $8K |
| 87040 | 5.0% | 1,302 | 1,097 | $7K | |
| 85027 | 4.9% | 16,690 | 8,431 | $7K | |
| 83880 | 4.1% | 626 | 551 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.8% | 165 | 137 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.6% | 185 | 169 | $4K |
| 80306 | 2.6% | 292 | 244 | $4K | |
| 84484 | 2.4% | 3,457 | 2,347 | $4K |
67 more codes
| 84703 | 1.9% | 1,285 | $3K | |
| 88307 | 1.6% | 44 | $2K | |
| 87275 | 1.4% | 356 | $2K | |
| 82805 | 1.4% | 323 | $2K | |
| 83735 | 1.3% | 3,652 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 842 | $2K |
| 87400 | 1.1% | 200 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 84 | $2K |
| 83605 | 1.0% | 1,390 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 389 | $1K |
| 85730 | <1% | 3,472 | $1K | |
| 87430 | <1% | 202 | $1K | |
| 84702 | <1% | 274 | $1K | |
| 87276 | <1% | 1,042 | $895.74 | |
| 85610 | <1% | 4,142 | $862.21 | |
| 81025 | <1% | 1,150 | $861.87 | |
| 84100 | <1% | 1,702 | $813.04 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,025 | $745.86 |
| 83690 | <1% | 2,420 | $727.84 | |
| 87070 | <1% | 1,363 | $700.83 | |
| 80076 | <1% | 1,563 | $669.38 | |
| 80061 | Lipid panel | <1% | 329 | $623.79 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 573 | $599.94 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 72 | $573.82 |
| 86850 | <1% | 1,328 | $485.04 | |
| 82247 | <1% | 844 | $451.40 | |
| 86880 | <1% | 131 | $357.21 | |
| 87340 | <1% | 113 | $344.82 | |
| 81001 | <1% | 1,795 | $308.16 | |
| 86901 | <1% | 1,979 | $251.09 | |
| 81003 | <1% | 1,917 | $234.37 | |
| 86900 | <1% | 2,038 | $232.10 | |
| 84450 | <1% | 565 | $225.09 | |
| 84075 | <1% | 560 | $224.19 | |
| 84460 | <1% | 562 | $195.24 | |
| 84155 | <1% | 558 | $180.78 | |
| 82040 | <1% | 565 | $143.64 | |
| 82550 | <1% | 327 | $126.79 | |
| 82553 | <1% | 131 | $115.50 | |
| 85379 | <1% | 348 | $108.80 | |
| 82803 | <1% | 16 | $98.04 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 84 | $75.62 |
| 87807 | <1% | 79 | $72.20 | |
| 87802 | <1% | 13 | $67.51 | |
| 80047 | <1% | 33 | $64.74 | |
| 86140 | <1% | 252 | $40.87 | |
| 82728 | <1% | 50 | $31.29 | |
| 84550 | <1% | 31 | $29.61 | |
| 82248 | <1% | 187 | $27.50 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 100 | $26.43 |
| 80202 | <1% | 24 | $22.70 | |
| 87205 | <1% | 75 | $21.75 | |
| 87081 | <1% | 74 | $16.02 | |
| 80320 | <1% | 15 | $15.92 | |
| 86738 | <1% | 14 | $10.62 | |
| 83615 | <1% | 115 | $10.53 | |
| 82150 | <1% | 15 | $9.72 | |
| 85384 | <1% | 30 | $8.52 | |
| 87077 | <1% | 12 | $7.95 | |
| 85018 | <1% | 98 | $4.82 | |
| 85014 | <1% | 29 | $3.84 | |
| 87420 | <1% | 32 | $3.72 | |
| 83540 | <1% | 13 | $1.72 | |
| 85651 | <1% | 14 | $1.71 | |
| 87210 | <1% | 34 | $0.70 | |
| 86592 | 0% | 41 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.